Skip to main content

Advertisement

Table 1 Correlations between AGBL2 expression and clinicopathological features (n = 126)

From: Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer

Variables N AGBL2- AGBL2+ P value
Age     0.062
 <35 Y 18 14 4  
 >35 Y 108 60 48  
Tumor size     0.562
 T1 24 16 8  
 T2 83 46 37  
 T3 19 12 7  
Clinical stage     0.001
 I 15 14 1  
 II 57 45 12  
 III 54 15 39  
Tumor stage     0.151
 DCIS 16 7 9  
 IDC 110 67 43  
Metastatic nodes     0.006
 Negative 50 38 12  
 Positive 76 36 40  
Her2 status     0.632
 Positive 21 9 12  
 Negative 105 47 58